UK Companies House feature
HIKMA UK LIMITED
Profile
- Company number
- 05497478
- Status
- Active
- Incorporation
- 2005-07-03
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have assessed the ability of Hikma to provide that support and, on that basis, have concluded that the application of the going concern basis of preparation of the financial statements is appropriate.”
Subsidiaries
- Hikma Specialized Pharmaceuticals S.A.E · 97.7% held · Giza, Egypt
- Hikma Pharmaceuticals Industries (S.A.E) · 99.9% held · Giza, Egypt
- Hikma Pharma S.A.E · 99.9% held · Giza, Egypt
- Hikma for Importation Co. LLC · 98.9% held · Giza, Egypt
- Hikma d.o.o · 100% held · Zagreb (Grad Zagreb) Croatia
- Thymoorgan Pharmazie GmbH · 100% held · Goslar, OT Vienenburg, Germany
- Hikma Injectables USA Inc · 100% held · Dayton, New Jersey 08810
- West-Ward Columbus Inc · 100% held · Columbus, Ohio 43228
- Hikma Speciality USA Inc · 100% held · Columbus, Ohio 43228
- Eurohealth (U.S.A.) Inc · 100% held · Berkeley Heights, NJ 07922
- Hikma Canada Limited · 100% held · Mississauga ON L5R 3P9, Canada
- Hikma Finance USA LLC · 100% held · Berkeley Heights, NJ 07922
- Hikma Espana S.L · 100% held · Alcobendas, Madrid, Spain
- Hikma France · 100% held · Boulogne Billancourt, France
- Hikma Farmaceutica (Portugal) S.A · 100% held · Terrugem SNT, Portugal
- Hikma Pharma Benelux B.V · 100% held · Hoorn, Netherlands
- Hikma Pharma GmbH · 100% held · Martinsried, Germany
- Lifotec Farmaceutica S.G,P.S. S.A · 100% held · Sintra, Portugal
- Hikma Pharmaceuticals International Limited · 100% held · London, United Kingdom
- Hikma Services India Private Limited · 100% held · Mumbai, Maharashtra - 4000 57
- West-Ward Holdings Limited · 100% held · London, United Kingdom
- Hikma Pharmaceuticals USA Inc · 100% held · Berkeley Heights, NJ 07922
- Hikma Labs Inc · 100% held · Columbus, Ohio 43228
- TACCA LLC · 90% held · Carlsbad, CA 92011
- Pytrione LLC · 84.21% held · Carlsbad, CA 92011
Significant events
- “The Directors are not aware of any matter or circumstance arising since the end of the financial year that would significantly affect the operations of the Company or the results of its operations.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MIDDLEMIST, Helen | Secretary | 2022-07-18 | — | — |
| AL KURDI, Areb | Director | 2022-08-15 | Oct 1974 | Jordanian |
| KHOURI, Bana | Director | 2022-04-01 | Apr 1983 | British |
| MIDDLEMIST, Helen | Director | 2022-07-18 | Sep 1981 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES, Adam Mark | Secretary | 2005-07-03 | 2005-07-06 |
| KANAAN, Bassam Wael Roshdi | Secretary | 2005-07-06 | 2006-11-02 |
| KNOWLES, Henry James | Secretary | 2006-11-02 | 2010-10-01 |
| SPEIRS, Peter Alexander | Secretary | 2010-10-01 | 2022-06-15 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2005-07-03 | 2005-07-03 |
| ARKHAQA, Hussein | Director | 2006-10-05 | 2009-12-22 |
| ATWAL, Gurpal Singh | Director | 2013-02-21 | 2022-02-11 |
| CREASE, Thomas Michael | Director | 2013-07-18 | 2015-01-05 |
| EDEY, Kate | Director | 2005-07-03 | 2005-07-06 |
| HANSEN, Joanna Elizabeth | Director | 2020-03-30 | 2025-09-25 |
| HYDE, Jane Celia | Director | 2016-04-12 | 2018-10-09 |
| JONES, Adam Mark | Director | 2005-07-03 | 2005-07-06 |
| KANAAN, Bassam Wael Roshdi | Director | 2005-07-06 | 2006-11-02 |
| KNOWLES, Henry James | Director | 2006-10-05 | 2013-06-27 |
| LABADI, Majda Ali Abdelghani Mishlawi | Director | 2005-07-06 | 2013-02-21 |
| RINGDAL, Susan Eleanor Mulvihill | Director | 2006-10-05 | 2009-12-22 |
| SPEIRS, Peter Alexander | Director | 2013-02-21 | 2022-06-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Hikma Pharmaceuticals Public Limited Company | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-01-04 | Active |
| Hikma Holdings (Uk) Limited | Corporate entity | Shares 75–100% | 2016-05-25 | Ceased 2021-01-04 |
| Hikma Acquisitions (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2021-11-02 |
Filing timeline
Last 20 of 117 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-26 | TM01 | officers | termination director company with name termination date |
| 2025-09-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-23 | AA | accounts | accounts with accounts type full |
| 2024-09-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-02 | CH01 | officers | change person director company with change date |
| 2024-07-26 | AA | accounts | accounts with accounts type full |
| 2023-09-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-16 | AA | accounts | accounts with accounts type full |
| 2022-10-01 | AA | accounts | accounts with accounts type full |
| 2022-09-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-14 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2022-08-15 | AP01 | officers | appoint person director company with name date |
| 2022-07-18 | AP01 | officers | appoint person director company with name date |
| 2022-07-18 | AP03 | officers | appoint person secretary company with name date |
| 2022-06-23 | CH01 | officers | change person director company with change date |
| 2022-06-15 | TM01 | officers | termination director company with name termination date |
| 2022-06-15 | TM02 | officers | termination secretary company with name termination date |
| 2022-04-01 | AP01 | officers | appoint person director company with name date |
| 2022-02-14 | TM01 | officers | termination director company with name termination date |
| 2021-09-06 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.